Punjab has launched an aggressive campaign—supporting DRAP—to eliminate fake, substandard, and unregistered medicines from the market. In coordinated raids, authorities seized multiple batches of counterfeit drugs, triggered nationwide recall orders, and intensified stock checks in pharmacies and distribution networks.

The crackdown includes surprise inspections across major cities, targeting both smuggled and locally produced counterfeit products. Officials also strengthened supply chain surveillance and issued immediate recall alerts, urging pharmacies to quarantine suspicious stock and flag suppliers. A dedicated task force is now tracking the medicine market closely using new barcode‑scanning tools and mobile app verification to help consumers confirm authenticity.

Health authorities stress that fake medicines can cause therapy failures, severe side effects, and deadly outcomes, particularly among vulnerable groups like the elderly and immunocompromised. They have vowed to maintain ongoing monitoring and legal action to ensure medicines sold meet quality and safety standards.

This intensified enforcement by Punjab’s health department and DRAP marks a critical step toward restoring public trust and protecting healthcare systems from the dangers posed by counterfeit pharmaceuticals.